RTN2
Basic information
Region (hg38): 19:45485294-45497055
Previous symbols: [ "SPG12" ]
Links
Phenotypes
GenCC
Source:
- hereditary spastic paraplegia 12 (Supportive), mode of inheritance: AD
- neuronopathy, distal hereditary motor, autosomal recessive 11, with spasticity (Strong), mode of inheritance: AR
- hereditary spastic paraplegia 12 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spastic paraplegia 12, autosomal dominant; Neuronopathy, distal hereditary motor, autosomal recessive 11, with spasticity | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 10677333; 12427890; 22232211; 38527963 |
ClinVar
This is a list of variants' phenotypes submitted to
- Spastic paraplegia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RTN2 gene is commonly pathogenic or not. These statistics are base on transcript: . Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 42 | 52 | ||||
missense | 119 | 14 | 135 | |||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
Total | 1 | 9 | 126 | 56 | 9 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RTN2 | protein_coding | protein_coding | ENST00000245923 | 11 | 11773 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.416 | 0.584 | 125740 | 0 | 5 | 125745 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.701 | 306 | 343 | 0.893 | 0.0000224 | 3403 |
Missense in Polyphen | 90 | 110.9 | 0.81151 | 1091 | ||
Synonymous | 0.725 | 144 | 155 | 0.926 | 0.0000103 | 1214 |
Loss of Function | 4.05 | 7 | 31.5 | 0.222 | 0.00000206 | 293 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000548 | 0.0000544 |
Finnish | 0.0000468 | 0.0000462 |
European (Non-Finnish) | 0.0000178 | 0.0000176 |
Middle Eastern | 0.0000548 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
Intolerance Scores
- loftool
- 0.619
- rvis_EVS
- -0.2
- rvis_percentile_EVS
- 39.11
Haploinsufficiency Scores
- pHI
- 0.590
- hipred
- N
- hipred_score
- 0.322
- ghis
- 0.527
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.830
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rtn2
- Phenotype
- muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- regulation of glucose import;intracellular protein transmembrane transport
- Cellular component
- endoplasmic reticulum;terminal cisterna;integral component of endoplasmic reticulum membrane;T-tubule
- Molecular function
- protein binding